Gainesville, FL Clinical Trials Report — June 2026

June 2026 presents a dynamic landscape for clinical trial participation in Gainesville, FL, with both urgent opportunities and significant new research initiatives. Across the city, 540 clinical trials are actively recruiting participants at 173 research facilities, offering diverse avenues to contribute to medical advancements.

For those considering participation, prompt action is advised for a number of studies. A total of 34 trials are slated to conclude their enrollment within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 9 of these rapidly closing studies are still actively seeking participants without specific health conditions. These trials offer a chance to contribute to medical advancements before their enrollment windows close.

Impending Deadlines for Key Health Areas

Patients managing specific health conditions also face impending deadlines to join research. Trials focused on various conditions are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Duchenne muscular dystrophy (2 trials)
• Sepsis (2 trials)
• Aging well (1 trial)
• Alcohol use (1 trial)
• Aortic insufficiency (1 trial)
• Aortic regurgitation (1 trial)
• Attention-deficit/hyperactivity disorder (1 trial)
• Aortic valve insufficiency (1 trial)
• Autonomic state (1 trial)
• Back pain (1 trial)

New Research Opportunities Emerge This Month

This month, Gainesville saw the opening of 4 new clinical trials, a slight decrease from the 6 trials that launched in May 2026. These new studies bring fresh opportunities for participants across various health interests.

A notable new trial this month is a significant Phase 3 study sponsored by the University of Florida:

• NCT07670650: "PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study." This Phase 3, multicenter, randomized, double-blind, placebo-controlled study will evaluate the efficacy, safety, and tolerability of SAB-142, a fully human anti-thymocyte globulin (h-ATG), in participants aged 5 to 40 years with Stage 3 type 1 diabetes (T1D). The study aims to enroll 108 participants.

New trials this month are exploring a range of conditions, including:

• Healthy adult participants (1 trial)
• Heart failure with preserved ejection fraction (HFpEF) (1 trial)
• Parkinson disease (1 trial)
• Parkinsonism (1 trial)
• Type 1 diabetes (T1D) (1 trial)

Of the new studies, 2 are drug trials and 2 are classified as "OTHER" trial types. The University of Florida is the sponsor for all 4 new trials, highlighting its strong commitment to advancing medical research in the region.

Opportunities for Healthy Volunteers

For individuals without a specific medical condition, there are significant opportunities to contribute to research. Of the 4 new trials launched this month, 1 is actively seeking healthy volunteers. Across Gainesville, a total of 74 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

Gainesville's Leading Research Facilities

Gainesville is home to several prominent research institutions that consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• University of Florida (193 trials)
• UF Health Cancer Institute - Gainesville (58 trials)
• Research Site (16 trials)
• North Florida/South Georgia Veterans Health System, Gainesville, FL (12 trials)
• University of Florida Health (12 trials)
• University of Florida College of Medicine (8 trials)
• Vitreo Retinal Associates (8 trials)
• Malcom Randall Veterans Administration Medical Center (8 trials)
• UF Health (7 trials)
• UF Health Shands Hospital (7 trials)
• University of Florida Shands Hospital (6 trials)
• Norman Fixel Institute for Neurological Diseases (6 trials)

These institutions offer a broad spectrum of research, from comprehensive medical studies at the University of Florida and UF Health, to specialized care at the UF Health Cancer Institute and the Norman Fixel Institute for Neurological Diseases.

Broadening Your Search: Nearby Options

While Gainesville offers a robust array of clinical trial opportunities, individuals may also find options in nearby communities within Florida. Cities with active trials include Miami (24 trials), Jacksonville (17 trials), Orlando (16 trials), Tampa (13 trials), Maitland (8 trials), Ocala (7 trials), Leesburg (6 trials), and Ocoee (5 trials).

Participation in clinical trials is open to a diverse range of individuals. Of the 4 new trials launched this month, 1 includes children and 3 include older adults. There are no new female-only or male-only trials this month. Academic institutions, particularly the University of Florida, continue to play a vital role in Gainesville's research ecosystem, sponsoring all new studies this month.

As we move through June, Gainesville's active research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare.